Simone is driven by a deep passion—some might call it an obsession—for the dynamic intersection of consumer experience, technology, health, and wellbeing. She believes the future of healthcare lies in seamlessly integrating cutting-edge technology and consumer-focused solutions to elevate patient care and drive meaningful outcomes. This conviction fuels her work with digital health and biotechnology innovators, AI-driven healthcare enterprises, and institutional investors, as she helps them navigate the complex legal and regulatory challenges that arise at this crossroads.

Simone joins AHL with a decade of experience structuring complex transactions, negotiating commercial agreements, and providing day-to-day operational and compliance counsel for a broad spectrum of healthcare clients. Her clients include institutional investors, health systems and healthcare providers, pharmaceutical and medical device companies, digital health companies, specialty pharmacies, and AI-driven healthcare enterprises. Simone is adept at counseling clients on regulatory issues such as licensure and accreditation, fee-splitting and the corporate practice of medicine, health information privacy, healthcare fraud and abuse, and the various complex legal frameworks that govern innovation in the healthcare sector.

She is recognized for her ability to partner with executives and senior management to navigate rapidly evolving regulatory landscapes, ensuring strategic growth while maintaining ethical integrity, equity, and transparency. Simone is a trusted advisor to healthcare organizations seeking to harness the power of AI and data, offering practical solutions that balance innovation with compliance and risk management.

SERVICES

• Digital Health/Technology Transactions

• Healthcare Startups/Scale-ups

• Outside General Counsel

• Regulatory/Compliance

• Mergers/Acquisitions

• Pharmacy

• Healthcare Practitioners

PRIOR EXPERIENCE & REPRESENTATIVE MATTERS

Simone has represented a diverse array of healthcare and technology clients, including:

• Advising a digital health platform dedicated to providing culturally competent maternal care in connection with its national launch.
  

• Counseling an early-stage AI breast cancer detection company through a $3.5 million Series Seed financing.
  

• Representing a venture capital firm in a $20 million Series A investment in a virtual-first medical practice focused on digestive health.
  

• Advising on a $75 million Series D investment in a subscription-based nutrition platform.
  

• Counseling the launch of a digital-first service connecting women to healthcare providers for alternative medicine wellness support and resources.
  

• Counseling an early-stage biotechnology company through the launch of a clinical research study to support the development of the company’s flagship product.
  

• Advising a private equity firm on the acquisition of a provider of remote cardiac monitoring services.
  

• Advised an FDA 503A and 503B compounding pharmacy on its acquisition of a suite of companies focused on health and wellness, providing several products and services, including specialty pharmacy, prescription compounding, cosmeceuticals, nutritional supplements, lab services and testing, software solutions for prescribers, and continuing education for medical practitioners.
  

• Advised a private investment firm on the sale of its portfolio company, a leading pharmacy innovator servicing long-term care facilities and communities, to a digital health platform providing personalized medication management software.
  

• Advised a health data network that allows customers to access and share health data across insurance, life sciences, and digital health companies, in connection with its sale for a purchase price of $100 million.
  

• Advised a private investment firm on the closing of its approximately $40 million investment in the approximately $63.5 million Series D Preferred Stock financing of a digital health platform that uses machine-learning technology to provide personalized care plans.
  

• Advised a venture capital firm in its $149 million investment in a company focused on acquiring, building, and growing enterprise software businesses, including EHR and EMR platforms.
  

• Advised a teletherapy provider partnering with higher education institutions to meet on-campus demands for care in the closing of its Series A extension financing.
  

• Advised a venture capital firm on the closing of its approximately $30 million investment in the Series A Preferred Stock financing of a teletherapy platform partnering with colleges to provide online mental health and wellness counseling for students.
  

• Advised an emerging cannabis multi-state operator in the acquisition of nine retail stores and three cultivation and production facilities in New York, Massachusetts, and Illinois for a cash purchase price of $110 million, plus $45 million in seller financing and additional cash consideration based on market-growth milestones.

RECOGNITIONS

• Recognized in The Best Lawyers in America: “Ones to Watch,” for work in Health Care Law (2023-2025).

CREDENTIALS

Education

• Texas Law, Austin, TX. Juris Doctor, 2015.

• Rice University, Houston, TX. Bachelor of Arts, Cognitive Science, 2008.

Professional Associations.

• American Health Law Association

• Legal Council on Legal Diversity

• Black Women in Venture Capital

Admissions.

• Texas

• New York

• District of Columbia

PRIOR POSITIONS

• Goodwin Procter, LLP

• Baker Hostetler, LLP

• McGinnis Lochridge, LLP

COMMUNITY INVOLVEMENT

• HerHealthEQ, Board of Directors, 2022-Present.

• Texas Law, Alumni Mentorship Program, Advisory Board, 2020-Present.

• Consortium for Technology and Innovation in Pediatrics MedTech Accelerator, Investor Advisory Board, 2023-Present.